Peritoneal function in clinical practice: The importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function

NDT Plus

Volumn 2, Issue 2, 2009, Pages 104-110

  Coester, Annemieke M ^a   Smit, Watske ^a,b   Struijk, Dirk G ^a,b   Krediet, Raymond T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Dianet Foundation   (Netherlands)

Author keywords

Long term PD; Peritoneal dialysis; Peritoneal function; Recommendations; Ultrafiltration failure

Indexed keywords

CLINICAL PRACTICE; FOLLOW UP; HUMAN; PATHOPHYSIOLOGY; PATIENT INFORMATION; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONEUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION;

EID: 77953941491     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn203     Document Type: Review

References (79)

1. Krediet RT, Boeschoten EW, Dekker FW. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? Semin Dial 2007; 20: 205-208
2. Krediet RT. Advances in peritoneal dialysis. Minerva Urol Nephrol 2007; 59: 251-260
3. Van Den Wall Bake AWL, Kooman JP, Lange JM et al. Adequacy of peritoneal dialysis and the importance of preserving residual renal function. Nephrol Dial Transplant 2006; 21(Suppl 2): 34-37
4. Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant 2006; 21(Suppl 2): 42-46
5. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41-45
6. Honda K, Nitta K, Horita S et al. Morphological changes in the vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-176
7. Mateijsen MAM, Van Der Wal AC, Hendriks PMEM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525
8. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
9. Imholz ALT, Koomen GCM, Struijk DG et al. The effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int 1993; 44: 1078-1085
10. Twardowski ZJ, Khanna R, Nolph KD et al. Intra-abdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 129-135
11. Twardowski ZJ, Prowant BF, Nolph KD et al. High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23: 64-70
12. Ho-dac-Pannekeet MM, Schouten N, Langedijk MJ et al. Peritoneal transport characteristics with glucose polymer dialysate. Kidney Int 1996; 50: 979-986
13. Imholz ALT, Koomen GCM, Struijk DG et al. Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994; 46: 333-340
14. Rippe B, Stelin G. Simultations of peritoneal solute transport during CAPD. Application of two-pore formatism. Kidney Int 1989; 35: 1234-1244
15. Pannekeet MM, Mulder JB, Weening JJ et al. Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients. Perit Dial Int 1996; 16(Suppl 1): S54-S57
16. Nolph KD, Hano JE, Teschan PE. Peritoneal sodium transport during hypertonic peritoneal dialysis. Ann Intern Med 1969; 70: 931-941
17. Nolph KD, Twardowski ZJ, Popovich RP et al. Equilibiration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 1979; 93: 246-256
18. Ni J, Verbavatz JM, Rippe A et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006; 69: 1518-1525
19. Smit W, Struijk DG, Ho-dac-Pannekeet MM et al. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66: 849-854
20. Parikova A, Smit W, Struijk DG et al. The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. Kidney Int 2005; 68: 1849-1856
21. Rippe B. Free water transport small pore transport and the osmotic pressure gradient three pore model of peritoneal transport. Nephrol Dial Transplant 2008; 23: 2147-2153
22. Smit W, Van Dijk P, Langedijk MJ et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440-449
23. Michels WM, Zweers MM, Smit W et al. Does lymphatic absorption change with the duration of peritoneal dialysis? Perit Dial Int 2004; 24: 347-352
24. Krediet RT. The effective lymphatic absorption rate is an accurate and useful concept in the physiology of peritoneal dialysis. Perit Dial Int 2004; 24: 309-317
25. Coester AM, Struijk DG, Smit W et al. The cellular contribution to effluent potassium and its relation with free water transport during peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 3593-3600
26. Churchill DN, Thorpe KE, Nolph KD et al. for the CANUSA Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9: 1285-1292
27. Chung SH, Chu WS, Lee HA et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20: 541-547
28. Rumpsfeld M, McDonald SP, Purdie DM et al. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004; 43: 492-501
29. Topley N, Williams JD. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 1994; 46(Suppl 48): S71-S78
30. Selgas R, Del Peso G, Bajo M-A et al. Spontaneous VEGF production by culturedmesothelial cells from patients on peritoneal dialysis. Perit Dial Int 2000; 20: 798-801
31. Visser CE, Brouwer-Steenbergen JJE, Betjes MGH et al. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10: 64-69
32. Topley N, J̈orres A, Luttmann W et al. Human peritoneal mesothelial cells synthesize IL-6: induction by IL-Iβ and TNFαKidney Int 1993;43:226-233
33. Betjes MGH, Tuk CW, Struijk DG et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-α, interleukin-1 and medium conditions by macrophages cocultured with staphylococcus epidermidis. J Infect Dis 1993; 168: 1202-1210
34. Ho-Dac-Pannekeet MM, Krediet RT. Inflammatory changes in vivo during CAPD.What can the effluent tell us? Kidney Int 1996; 50(Suppl 56): S12-S16
35. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21: 560-567
36. Davies SJ, Brian J, Phillips L et al. The predictive value of Kt/V and peritoneal solute transport in CAPD patients in dependent on the type of comorbidity present. Perit Dial Int 1990; 16(Suppl 1): S158-S162
37. Pecoits-Filho R, Araujo MRT, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486
38. Pecoits-Filho R, Carvalho MJ, Stenvinkel P et al. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int 2006; 26: 53-63
39. Rodrigues A, Almeida M, Fonseca I et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 2006; 21: 763-769
40. Rodrigues AS, Martins M, Korevaar JC et al. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 2007; 27: 84-91
41. Van Esch S, Zweers MM, Jansen MAM et al. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int 2004; 24: 554-561
42. Lo WK, Brendolan A, Prowant BF et al. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 1994; 4: 1466-1474
43. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG et al. Longitudinal follow-up of CA 125 in peritoneal effluent. Kidney Int 1997; 51: 888-893
44. Van Olden RW, Guchelaar H-J, Struijk DG et al. Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int 2003; 23: 339-347
45. Medcalf JF, Harris KPG, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59: 1128-1133
46. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW et al. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987; 17: 43-52
47. Douma CE, DeWaart DR, Struijk DG et al. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? J Lab Clin Med 1998; 132: 329-340.
48. Smit W, Van Den Berg N, Schouten N et al. Free water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD. Kidney Int 2004; 65: 298-303
49. Zemel D, Koomen GCM, Hart AAM et al. Relationship of TNF-α, interleukin-6 and prostogladins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686-696
50. Gokal R, Mistiy CD, Peers EM MIDAS Study Group. Peritonitis occurrence in a multicentre study of icodextrin and glucose in CAPD. Perit Dial Int 1994; 15: 226-230
51. Posthuma N, TerWee PM, Donker AJM et al. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disacharide concentrations. Nephrol Dial Transplant 1998; 13: 2341-2344
52. Smit W, Schouten N, Van Den Berg N et al. for the Netherlands Ultrafiltration failure study group. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross sectional study. Perit Dial Int 2004; 24: 562-570
53. Smit W, Parikova A, Struijk DG et al. The difference in causes of early and late ultrafiltration failure in peritoneal dialysis. Perit Dial Int 2005; 25(Suppl 3): S41-S45 (Pubitemid 40883213)
54. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66: 2437-2445
55. Parikova A, Smit W, Struijk DG et al. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 2006; 70: 1988-1994
56. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG et al. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51: 888-893
57. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome study. J Am Soc Nephrol 2003; 14: 2948-2957
58. Jansen MAM, Termorshuizen F, Korevaar JC et al. for the NECOSAD study group. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68: 119-1205
59. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138-147
60. Smit W, Langedijk MJ, Schouten N et al. A comparison between 1.36% and 3.86% glucose solutions for the assessment of peritoneal membrane function. Perit Dial Int 2000; 20: 734-741
61. Parikova A, Struijk DG, Zweers MM et al. Does the biocompatibility of the PD solution matter for the assessment of peritoneal function? Perit Dial Int 2007; 27: 691-696
62. Nolph K, Gokal R, Mujais S et al. ISPD ad hoc committee on ultrafiltration management in peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 4): S3-S4
63. Virga G, Amici G, Da Rin G et al. Comparison of fast peritoneal equilibration test with 1.36% and 3.86% dialysis solution. Blood Purif 1994; 12: 113-120
64. Ho-dac-Pannekeet MM, Atasever B, Struijk DG et al. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of the standard peritoneal permeability analysis. Perit Dial Int 1997; 17: 144-150
65. Wang T, Waniewski J, Heimburger O et al. A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 1997; 52: 1609-1616
66. Westra WM, Smit W, Zweers MM et al. Diffusion correction of sodium sieving applicable in a peritoneal equilibration test. Adv Perit Dial 2003; 19: 6-9
67. La Milia V, Di Filippo S, Crepoldi M et al. Mini-peritoneal equilibration test: a simple and fast method to assess free water and small solute transport across the peritoneal membrane. Kidney Int 2005; 68: 840-846
68. Rodriquez AS, Silva S, Bravo F et al. Peritoneal membrane evaluation in routine clinical practice. Blood Purif 2007; 25: 497-504
69. La Milia V, Limardo M, Virga G et al. Simultaneous measurement of peritoneal glucose and free water osmotic conductances. Kidney Int 2007; 72: 643-650
70. Cnossen TT, Smit W, Konings CJA et al. Quantification of free water transport during the peritoneal equilibration test. Perit Dial Int; in press
71. Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 1995; 47: 1187-1198
72. Van Biesen W, Van Der Tol A, Veys N et al. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2006; 1: 269-274
73. Sanusi AA, Zweers MM, Weening JJ et al. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of nitroneal dialysis. Perit Dial Int 2001; 21: 495-500
74. Akman S, Van Westrhenen R, De Waart DR et al. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patïents on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2003; 19: 24-27.8
75. The EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. Nephrol Dial Transplant 2005; 20 (SUPPL. 9) S24-S27
76. Ates K, Nergizoglu G, Keven K et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767-776
77. Bargman JM, Thorpe KE, Churchill DN. for the CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162
78. Termorshuizen F, Korevaar JC, Dekker FW et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302
79. Lo WK, Bargman JM, Burkart J et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26: 520-522